Albany, New York, July 13, 2018: A new detailed study titled “Oral Thin Films Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 – 2026” has recently been submitted to the repository of Market Research Reports Search Engine (MRRSE). According to the research study, the global oral thin films market is likely to grow at a CAGR of nearly 13% during the assessment period 2018-2026.
According to the research study, advantages of oral thin films over conventional capsules and tablets is driving their adoption in the market. Oral thin films are used to treat a wide range of ailments, including erectile dysfunction, migraine, nausea, and opioid dependence. Sublingual oral thin films are also gaining traction among end-users as they are a better substitute to oral capsules. On the back of these factors, the demand for oral thin films is likely to witness an increase over the course of the forecast period.
In a bid to offer detailed insights to readers, the research report offers in-depth analysis and forecast. The business intelligence study offers segment-wise analysis and forecast, segmenting the market on a range of parameters. The report segments the global oral thin films market into disease indication market, distribution channel market, product market and region market. The disease indication segment is further divided into schizophrenia, opioid dependence, migraine, nausea & vomiting and others. The distribution channel segment is sub-segmented into drug store, E-Commerce, hospital pharmacies and retail pharmacies. The product segment is bifurcated into fast dissolving dental/buccal film and sublingual film.
Geographically, the market is divided into key regions globally which are Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. According to the research report, demand for oral thin films is likely to witness an increase in North America on account of a host of factors. The market is likely to witness steady growth in the US, whereas Canada is likely to account for a miniscule share of the market. In addition to North America, demand for oral thin films is likely to witness steady growth in Asia Pacific, where a number of countries are focusing on delivering high quality care and services to end users.
The report profiles some of the leading players operating in the market. Some of these players are ZIM Laboratories Limited, Aquestive Therapeutics, Inc., IntelGenx Corp., Novartis AG, NAL Pharma, Indivior plc, Sumitomo Dainippon Pharma Co., Ltd., Pfizer, Inc., Allergan plc and Solvay. The product and business strategies of these key players, along with information on financial parameters has been included in the research study.
Browse Full Global Oral Thin Films Market Report with TOC : https://www.mrrse.com/oral-thin-films-market
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
90, State Street
Albany, NY – 12207